Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2019
Price : $35 *
At a glance
- Drugs Enzalutamide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms STREAM
- 12 Jun 2019 Status changed from active, no longer recruiting to completed.
- 13 May 2019 Planned End Date changed from 1 Jun 2019 to 1 Jul 2019.
- 05 Apr 2019 Planned End Date changed from 1 Mar 2019 to 1 Jun 2019.